skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: NUS Single-Journal Subscriptions remover idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Jacobson, Ira M, Prof ; Dore, Gregory J, Prof ; Foster, Graham R, Prof ; Fried, Michael W, Prof ; Radu, Monica, MD ; Rafalsky, Vladimir V, Prof ; Moroz, Larysa, Prof ; Craxi, Antonio, Prof ; Peeters, Monika, MSc ; Lenz, Oliver, PhD ; Ouwerkerk-Mahadevan, Sivi, PhD ; De La Rosa, Guy, MD ; Kalmeijer, Ronald, MD ; Scott, Jane, PhD ; Sinha, Rekha, PhD ; Beumont-Mauviel, Maria, PhD

The Lancet (British edition), 2014-08, Vol.384 (9941), p.403-413 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Petrology, geochronology, and tectonic implications of c. 500 Ma metamorphic and igneous rocks along the northern margin of the Central Asian Orogen (Olkhon Terrane, Lake Baikal, Siberia)
Petrology, geochronology, and tectonic implications of c. 500 Ma metamorphic and igneous rocks along the northern margin of the Central Asian Orogen (Olkhon Terrane, Lake Baikal, Siberia)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Petrology, geochronology, and tectonic implications of c. 500 Ma metamorphic and igneous rocks along the northern margin of the Central Asian Orogen (Olkhon Terrane, Lake Baikal, Siberia)

Gladkochub, Dmitry P ; Donskaya, Tatiana V ; Wingate, Michael T. D ; Poller, Ulrike ; Kröner, Alfred ; Fedorovsky, Valentin S ; Mazukabzov, Anatoliy M ; Todt, Wolfgang ; Pisarevsky, Sergei A

Journal of the Geological Society, 2008-01, Vol.165 (1), p.235-246 [Periódico revisado por pares]

London: Geological Society of London

Texto completo disponível

Citações Citado por
3
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial

Mega, JL, MD ; Braunwald, E, Prof ; Mohanavelu, S, MS ; Burton, P, MD ; Poulter, R, MB ; Misselwitz, F, MD ; Hricak, V, Prof ; Barnathan, ES, MD ; Bordes, P, MD ; Witkowski, A, Prof ; Markov, V, Prof ; Oppenheimer, L, PhD ; Gibson, CM, MD

The Lancet (British edition), 2009-07, Vol.374 (9683), p.29-38 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia
Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia

RHODES, Tim ; PLATT, Lucy ; JUDD, Ali ; MIKHAILOVA, Larissa Albertovna ; SARANG, Anya ; WALLIS, Nigel ; ALPATOVA, Tatiana ; HICKMAN, Matthew ; PARRY, John V

International journal of STD & AIDS, 2005-11, Vol.16 (11), p.749-754 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
5
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Dalton, Tracy, Dr ; Cegielski, Peter, MD ; Akksilp, Somsak, MD ; Asencios, Luis, MPH ; Caoili, Janice Campos, MD ; Cho, Sang-Nae, Prof ; Erokhin, Vladislav V, MD ; Ershova, Julia, PhD ; Gler, Ma Tarcela, MD ; Kazennyy, Boris Y, MD ; Kim, Hee Jin, MD ; Kliiman, Kai, MD ; Kurbatova, Ekaterina, MD ; Kvasnovsky, Charlotte, MD ; Leimane, Vaira, MD ; van der Walt, Martie, PhD ; Via, Laura E, PhD ; Volchenkov, Grigory V, MD ; Yagui, Martin A, MD ; Kang, Hyungseok, MD

The Lancet (British edition), 2012-10, Vol.380 (9851), p.1406-1417 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials
Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials

Holmes, Michael V, DLSHTM ; Newcombe, Paul, PhD ; Hubacek, Jaroslav A, PhD ; Sofat, Reecha, PhD ; Ricketts, Sally L, PhD ; Cooper, Jackie, MSc ; Breteler, Monique MB, Prof ; Bautista, Leonelo E, DrPH ; Sharma, Pankaj, MD ; Whittaker, John C, Prof ; Smeeth, Liam, Prof ; Fowkes, F Gerald R, Prof ; Algra, Ale, Prof ; Shmeleva, Veronika, MD ; Szolnoki, Zoltan, PhD ; Roest, Mark, PhD ; Linnebank, Michael, MD ; Zacho, Jeppe, MD ; Nalls, Michael A, PhD ; Singleton, Andrew B, PhD ; Ferrucci, Luigi, MD ; Hardy, John, Prof ; Worrall, Bradford B, MD ; Rich, Stephen S, Prof ; Matarin, Mar, PhD ; Norman, Paul E, FRACS ; Flicker, Leon, FRACP ; Almeida, Osvaldo P, Prof ; van Bockxmeer, Frank M, Prof ; Shimokata, Hiroshi, Prof ; Khaw, Kay-Tee, Prof ; Wareham, Nicholas J, Prof ; Bobak, Martin, Prof ; Sterne, Jonathan AC, Prof ; Smith, George Davey, Prof ; Talmud, Philippa J, Prof ; van Duijn, Cornelia, Prof ; Humphries, Steve E, Prof ; Price, Jackie F, FFPH ; Ebrahim, Shah, Prof ; Lawlor, Debbie A, Prof ; Hankey, Graeme J, FRACP ; Meschia, James F, Prof ; Sandhu, Manjinder S, PhD ; Hingorani, Aroon D, Prof ; Casas, Juan P, Dr

The Lancet (British edition), 2011-08, Vol.378 (9791), p.584-594 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Fuchs, Charles S, Dr Prof ; Tomasek, Jiri, MD ; Yong, Cho Jae, Prof ; Dumitru, Filip, MD ; Passalacqua, Rodolfo, MD ; Goswami, Chanchal, Prof ; Safran, Howard, Prof ; dos Santos, Lucas Vieira, MD ; Aprile, Giuseppe, MD ; Ferry, David R, Prof ; Melichar, Bohuslav, Prof ; Tehfe, Mustapha, MD ; Topuzov, Eldar, Prof ; Zalcberg, John Raymond, Prof ; Chau, Ian, MD ; Campbell, William, Prof ; Sivanandan, Choondal, MD ; Pikiel, Joanna, MD ; Koshiji, Minori, MD ; Hsu, Yanzhi, PhD ; Liepa, Astra M, PharmD ; Gao, Ling, PhD ; Schwartz, Jonathan D, MD ; Tabernero, Josep, MD

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

Bissler, John J, Prof ; Kingswood, J Christopher, FRCP ; Radzikowska, Elżbieta, MD ; Zonnenberg, Bernard A, MD ; Frost, Michael, MD ; Belousova, Elena, Prof ; Sauter, Matthias, MD ; Nonomura, Norio, Prof ; Brakemeier, Susanne, MD ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Chen, David, PhD ; Sahmoud, Tarek, MD ; Shah, Gaurav, MD ; Lincy, Jeremie, MS ; Lebwohl, David, MD ; Budde, Klemens, Prof

The Lancet (British edition), 2013-03, Vol.381 (9869), p.817-824 [Periódico revisado por pares]

Kidlington: Elsevier

Texto completo disponível

Citações Citado por
9
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

Franz, David Neal, Prof ; Belousova, Elena, MD ; Sparagana, Steven, MD ; Bebin, E Martina, MD ; Frost, Michael, MD ; Kuperman, Rachel, MD ; Witt, Olaf, MD ; Kohrman, Michael H, MD ; Flamini, J Robert, MD ; Wu, Joyce Y, MD ; Curatolo, Paolo, Prof ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Thiele, Elizabeth A, MD ; Ford, James P, MS ; Shah, Gaurav, MD ; Cauwel, Helene, MSc ; Lebwohl, David, MD ; Sahmoud, Tarek, MD ; Jozwiak, Sergiusz, MD

The Lancet (British edition), 2013-01, Vol.381 (9861), p.125-132 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Navarra, Sandra V, MD ; Guzmán, Renato M, MD ; Gallacher, Alberto E, MD ; Hall, Stephen, MD ; Levy, Roger A, MD ; Jimenez, Renato E, MD ; Li, Edmund K-M, MD ; Thomas, Mathew, MD ; Kim, Ho-Youn, MD ; León, Manuel G, MD ; Tanasescu, Coman, MD ; Nasonov, Eugeny, MD ; Lan, Joung-Liang, MD ; Pineda, Lilia, MD ; Zhong, Z John, PhD ; Freimuth, William, MD ; Petri, Michelle A, MD

The Lancet (British edition), 2011, Vol.377 (9767), p.721-731 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (68)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (70)
  2. magazinearticle  (2)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1998  (6)
  2. 1998Até2002  (7)
  3. 2003Até2006  (19)
  4. 2007Até2011  (29)
  5. Após 2011  (12)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.